Newborn lung treatment poses risk of intestinal perforation.
D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D002908:Chronic Disease; D003907:Dexamethasone / Q000009:adverse effects*; D006801:Humans; D007231:Infant, Newborn; D019102:Infant, Very Low Birth Weight; D007416:Intestinal Perforation / Q000139:chemically induced*; D012127:Respiratory Distress Syndrome, Newborn / Q000188:drug therapy*; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D003907:Dexamethasone